|
Aug 5
|
BioStem Technologies to Report Second Quarter 2024 Financial Results on Monday, August 12, 2024
|
|
Jun 17
|
UPDATE -- PRISM MarketView Showcases BioStem Technologies: Impressive Revenue Growth and Strategic Expansion
|
|
May 7
|
BioStem Technologies to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024
|
|
May 6
|
BioStem Technologies Granted Prioritized Examination for Wound Healing Patent
|
|
Mar 21
|
BioStem Technologies to Report Fourth Quarter 2023 Financial Results on Monday, April 01, 2024
|
|
Feb 1
|
BSEM: Investors Need to Pay Attention to BSEM
|
|
Jan 30
|
Amniowrap2™ Product Launch Leads Year of Highlights for BioStem Technologies
|
|
Jan 11
|
BioStem Technologies Appoints Proven Life Science Sales Leader Shawn McCarrey to Chief Commercial Officer Role
|
|
Dec 19
|
BioStem Technologies Appoints Executive Leader Patrick Daly to Board of Directors
|
|
Sep 29
|
BioStem Technologies: CMS Decision a “Win For Patients”
|
|
Jul 17
|
BSEM Provides Good Value for Great Science
|